HUATAI BIOPHARM INC.

E5G07
China Mainland
Company Profile
  • Year Established: 1998
  • Total Assets(USD): choose not to disclose
  • Total Number of Staff: less than 10 person
  • Annual Turnover(USD) : choose not to disclose
  • Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  Huatai Biopharm Inc. is the US FDA cGMP  approved leading manufacturer and supplier of ultra-pure and highly concentrated Omega-3 EPA/DHA Fatty Acids for pharmaceutical (Active Pharmaceutical Ingredient-API) and nutraceutical purpose.   Huatai Biopharm locates in Deyang, Sichuan, P.R. China. From it's foundation in 1998, Huatai Biopharm  dedicates to research and innovation of purification science and technologies to produce ultra-pure and highly concentrated Omega-3 EPA/DHA fatty acids. The unique and proprietary purification technologies enable the parameters for Oxidation and Environmental Pollutants approach to the most stringent quality standards,which exceed all known standards such as in GOED,  EU Pharmacopoeia (EP), US Pharmacopoeia (USP) Monograph.  

Year Established: 1998

Total Assets(USD): choose not to disclose

Total Number of Staff: less than 10 person

Annual Turnover(USD) : choose not to disclose

Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Top Products
Copyright 2006-2022 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182
Powered by